UK-500001 is an orally active inhibitor for phosphodiesterase 4 ( PDE4 ), which inhibits PDE4D3 ( IC 50 is 0.28 nM), PDE4B2 ( IC 50 is 22.8 nM), PDE4A4 ( IC 50 is 26.1 nM) and PDE4C2 ( IC 50 is 271 nM). UK-500001 exhibits anti-inflammatory efficacy and inhibits TNF-α and IFN-γ release in human and rodent macrophagic cell lines in nanomolar levels. UK-500001 ameliorates chronic obstructive pulmonary disease (COPD) and asthma.
Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Phosphodiesterase (PDE)
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.